Egypt, S.Arabia step up trade ties through coordination council talks    Egypt reviews progress on $200m World Bank-funded waste management hub    Egypt urges Israel to accept Gaza deal amid intensifying fighting    SCZONE showcases investment opportunities to eight Japanese companies    Egypt, ADIB explore strategic partnership in digital healthcare, investment    SCZONE, Tokyo Metropolitan Government sign MoU on green hydrogen cooperation    Egypt welcomes international efforts for peace in Ukraine    Al-Sisi, Macron reaffirm strategic partnership, coordinate on Gaza crisis    Contact Reports Strong 1H-2025 on Financing, Insurance Gains    Egypt, India's BDR Group in talks to establish biologics, cancer drug facility    AUC graduates first cohort of film industry business certificate    Egyptian pound down vs. US dollar at Monday's close – CBE    Egypt's FM, Palestinian PM visit Rafah crossing to review Gaza aid    Egypt prepares unified stance ahead of COP30 in Brazil    Egypt recovers collection of ancient artefacts from Netherlands    Egypt harvests 315,000 cubic metres of rainwater in Sinai as part of flash flood protection measures    Egypt, Namibia explore closer pharmaceutical cooperation    Fitch Ratings: ASEAN Islamic finance set to surpass $1t by 2026-end    Renowned Egyptian novelist Sonallah Ibrahim dies at 88    Egyptian, Ugandan Presidents open business forum to boost trade    Al-Sisi says any party thinking Egypt will neglect water rights is 'completely mistaken'    Egypt's Sisi warns against unilateral Nile measures, reaffirms Egypt's water security stance    Egypt's Sisi, Uganda's Museveni discuss boosting ties    Egypt, Huawei explore healthcare digital transformation cooperation    Egypt's Sisi, Sudan's Idris discuss strategic ties, stability    Egypt to inaugurate Grand Egyptian Museum on 1 November    Greco-Roman rock-cut tombs unearthed in Egypt's Aswan    Egypt reveals heritage e-training portal    Sisi launches new support initiative for families of war, terrorism victims    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



European Medicines Agency confirms safety of AstraZenecavaccine
Published in Daily News Egypt on 13 - 03 - 2021

The European Medicines Agency (EMA) announced, lastThursday, that there is no indication the AstraZeneca-Oxford University vaccine against the novel coronavirus (COVID-19) is linked to an increased risk of blood clots.
"There is currently no indication that vaccine has caused these conditions, which are not listed as side effects," the EMA said in a statement.
The announcement follows in the wake of several European countries suspending the use of the AstraZeneca-Oxford University vaccine, due to fears that it caused blood clots.
The move comes after severe reactions and deaths, believed to be related to the vaccine jointly developed by AstraZeneca and Oxford University, were reported.
Denmark, Iceland, and Norway have all suspended the use of the AstraZeneca vaccine, whilst Italy banned the vaccine's use as a precaution after two men died in Sicily shortly after they receivedthe vaccine.
Another five European countries, namely Estonia, Latvia, Lithuania, Luxembourg, and Austria, announced the suspension of certain doses of the vaccine.
The Italian Medicines Agency (AIFA) said that the decision of suspension is "preventive". AIFA took the action after a 43-year-old Navy Officer died from a suspected heart attack a day after he received the vaccination. Another Italian national, identified as a 50-year-old, reportedly died 12 days after receiving the vaccine.
Dr Ahmed Salman, a senior Immunologist and Vaccinologist at the University of Oxford and a participant in developing the AstraZeneca-Oxford University vaccine, stressed that all scientific data available so far confirms there is no relationship between the vaccine and any severe reactions.
This evidence is based on data collected during studies and information on the ground from millions of people who have received the vaccine.
In statements on his Facebook account, Salman added that in the EU, 30 cases of blood clots have been reported out of nearly 5 million people who had been given the vaccine at various intervals.
He noted that this is the natural rate of clots occurrence in such a large trance of the general population under normal circumstances.


Clic here to read the story from its source.